Enveda is a biotech company focused on accelerating drug discovery by learning from natural life. It develops methods to read and translate nature’s chemistry at unprecedented speed and scale, enabling faster identification and characterization of bioactive molecules derived from natural sources. The company aims to bring nature-inspired medicines to markets worldwide, highlighting its work in building a pipeline of drug candidates through leveraging evolutionary biology and natural product chemistry. Based on its messaging, Enveda positions itself as a globally active organization in the life sciences and pharmaceutical research space.
No recent deals for this company.